[Validation of the FINDRISC (FINnish Diabetes RIsk SCore) for prediction of the risk of type 2 diabetes in a population of southern Spain. Pizarra Study].
about
A novel testing model for opportunistic screening of pre-diabetes and diabetes among U.S. adultsEvaluation of Finnish Diabetes Risk Score in screening undiagnosed diabetes and prediabetes among U.S. adults by gender and race: NHANES 1999-2010.A risk assessment model for type 2 diabetes in ChineseEvaluation of the Finnish Diabetes Risk Score (FINDRISC) as a screening tool for the metabolic syndrome.Validating prediction scales of type 2 diabetes mellitus in Spain: the SPREDIA-2 population-based prospective cohort study protocol.Evaluation of the Finnish Diabetes Risk Score to predict type 2 diabetes mellitus in a Colombian population: A longitudinal observational study.Impact of sex and age on the performance of FINDRISC: the HUNT Study in Norway.Performance of the Finnish Diabetes Risk Score and a Simplified Finnish Diabetes Risk Score in a Community-Based, Cross-Sectional Programme for Screening of Undiagnosed Type 2 Diabetes Mellitus and Dysglycaemia in Madrid, Spain: The SPREDIA-2 Study.Clinical practice guideline for the prevention, early detection, diagnosis, management and follow up of type 2 diabetes mellitus in adults.Evaluation of the Japanese Metabolic Syndrome Risk Score (JAMRISC): a newly developed questionnaire used as a screening tool for diagnosing metabolic syndrome and insulin resistance in Japan.A Mobile App for Identifying Individuals With Undiagnosed Diabetes and Prediabetes and for Promoting Behavior Change: 2-Year Prospective Study.Risk assessment and HbA1c measurement in Norwegian community pharmacies to identify people with undiagnosed type 2 diabetes - A feasibility study.Validation of DIABSCORE in screening for Type 2 Diabetes and prediabetes in Tunisian population
P2860
Q28544686-AAED6862-0113-4F6A-BEF5-36A150CA43B5Q33650310-1EA9F6EC-8A2D-48C1-9EEB-51BC6C40A9E4Q34015539-B21053CA-8244-4710-9C68-6CE5A7283B68Q34159256-B77747FF-666E-4459-B284-C5F97152046EQ35906741-1FE8D0B7-D0DE-4318-814E-1560C2873858Q36356684-9AE6BA68-9724-4247-9269-E3F8CAF60906Q37063733-BC846D38-1515-4F65-9763-07F922A19BB2Q37115361-E139C576-10EA-4E7E-B246-312DA06DCE08Q37154927-C4DEEE68-6A83-4194-94CA-7E2B4D3F8BDEQ37418577-5C4A1086-087A-4669-9386-5E02019B161EQ55240468-A27C1FCA-E876-44EC-BDD6-F6EE64B74166Q55405531-142ED6FF-2596-4500-A2A0-A7D62DC7800BQ58778969-5FAB5801-F7B3-4F78-9820-E44ADFA737BE
P2860
[Validation of the FINDRISC (FINnish Diabetes RIsk SCore) for prediction of the risk of type 2 diabetes in a population of southern Spain. Pizarra Study].
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
[Validation of the FINDRISC (F ...... outhern Spain. Pizarra Study].
@en
[Validation of the FINDRISC
@nl
type
label
[Validation of the FINDRISC (F ...... outhern Spain. Pizarra Study].
@en
[Validation of the FINDRISC
@nl
prefLabel
[Validation of the FINDRISC (F ...... outhern Spain. Pizarra Study].
@en
[Validation of the FINDRISC
@nl
P2093
P50
P1433
P1476
[Validation of the FINDRISC (F ...... outhern Spain. Pizarra Study].
@en
P2093
Eduardo García Fuentes
Federico Soriguer
Francisca Rodríguez
Isabel Esteva
María Soledad Ruiz de Adana
Sergio Valdés
P304
P356
10.1016/J.MEDCLI.2011.05.025
P407
P577
2011-09-21T00:00:00Z